Association of Telemonitoring With Hospitalization Rates and Quality of Life in Patients With End-stage Heart Failure and Implanted Left Ventricular Cardiac Assist Devices
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Heart Failure
- Sponsor
- University Hospital, Essen
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Number of days spent in the hospital due to VAD-associated complications
- Last Updated
- 5 years ago
Overview
Brief Summary
The current study aims to investigate whether telemedical monitoring in patients with terminal heart failure and an implanted left ventricular assist device (LVAD) has an influence on LVAD-associated complications, hospitalization rates and quality of life. This is a prospective observational study. Patients with terminal heart failure and an implanted LVAD, where the indication for telemonitoring has already been stated by the attending physician are included in the study. Written informed consent is obtained from all patients. The telemedical monitoring is carried out by the West German Center for Applied Telemedicine (WZAT) and includes a standardized telephone interview every 3 days. In addition, all patients are equipped with an INR measuring device, a body scale and a clinical thermometer by WZAT. The data is documented in an electronic case file (medPower®). In the event of abnormalities, the West German Heart and Vascular Center (WHGZ) is contacted, and all necessary measures are initiated.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age\> 18 years
- •Indication for telemedicine
- •Permanently implanted left ventricular assist device (VAD)
Exclusion Criteria
- •no possibility of telephone contact
- •patient does not speak german
- •incompliance
- •rejection or inability to give consent
Outcomes
Primary Outcomes
Number of days spent in the hospital due to VAD-associated complications
Time Frame: 6 months
VAD-associated complications are defined as * bleeding with the need for a transfusion * infection with the need for an antibiotic therapy * thrombosis with the need for a lysis therapy
Secondary Outcomes
- Change in quality of life from baseline(6 months)
- Change in depression from baseline(6 months)
- Number of VAD-associated complications(6 months)